Trial intelligence / Profile preview

Tetanus post-exposure prophylaxis assessment using Tetanus Quick Stick

NL-OMON23665Active, not recruiting

Sponsor
National Institute for Public Health and the Environment
Start
Oct 2012
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
Countries
1
01

Overview

Open-label, single-arm trial of Tetanus immune globulin and tetanus toxoid in Tetanus, sponsored by National Institute for Public Health and the Environment. Primary endpoints: Immune status by TQS, Immune status by vaccination history and 1 more. Started Oct 2012; status: active, not recruiting.

02

Drugs

Tetanus immune globulintetanus toxoid
03

Conditions

Tetanus

Beyond the preview

Go deeper on NL-OMON23665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call